title: Ease of use of the ELLIPTA dry powder inhaler: data from three randomised controlled trials in patients with asthma.
authors: Value Evidence and Outcomes, GlaxoSmithKline, Stockley Park, Uxbridge, UK.
authors: Henrik
authors: H
authors: Svedsater
authors: Respiratory Medicines Development Centre, GlaxoSmithKline, Uxbridge, UK.
authors: Loretta
authors: L
authors: Jacques
authors: Quantitative Sciences Division, GlaxoSmithKline, Uxbridge, UK.
authors: Caroline
authors: C
authors: Goldfrad
authors: Center for Genomics and Personalized Medicine, Wake Forest School of Medicine, Winston-Salem, NC, USA.
authors: Eugene R
authors: ER
authors: Bleecker
mesh_terms: D000280:Administration, Inhalation; D018927:Anti-Asthmatic Agents / Q000008:administration & dosage* / Q000627:therapeutic use; D001249:Asthma / Q000188:drug therapy*; D058995:Dry Powder Inhalers; D006801:Humans; D011795:Surveys and Questionnaires
chemical_list: D018927:Anti-Asthmatic Agents